Pharmacokinetics of islatravir in participants with moderate hepatic impairment. Matthews RP, Patel M, Liu W, Liu Y, et al. Antimicrob Agents Chemother 2025 Mar 5:e0155324. doi: 10.1128/aac.01553.

Read + Share

Amedeo Smart

Independent Medical Education

Matthews RP, Patel M, Liu W, Liu Y, et al. Pharmacokinetics of islatravir in participants with moderate hepatic impairment. Antimicrob Agents Chemother 2025 Mar 5:e0155324. doi: 10.1128/aac.01553.
PMID: 40042304